/INLB
INLB Stock - Item 9 Labs Corp.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for INLB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.17
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $21.76M | $21.94M | $8.12M | $4.93M | $1.38M |
| Gross Profit | $7.31M | $8.61M | $3.30M | $2.38M | $357,186 |
| Gross Margin | 33.6% | 39.3% | 40.6% | 48.2% | 26.0% |
| Operating Income | $-23,065,234 | $-5,601,263 | $-5,325,950 | $-4,382,212 | $-691,431 |
| Net Income | $-31,142,604 | $-10,905,772 | $-12,299,657 | $-10,631,157 | $-642,282 |
| Net Margin | -143.1% | -49.7% | -151.4% | -215.5% | -46.7% |
| EPS | $-0.33 | $-0.14 | $-0.20 | $-0.17 | $-0.23 |
Company Overview
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
INLBBeat Rate
29%
Last 7 quarters
Avg Surprise
-79.0%
EPS vs Estimate
Beats / Misses
2/4
1 met exactly
Latest EPS
$-0.06
Q3 2023
EPS Surprise History
Q1 22
No data
Q1 22
0.0%
$-0.04vs$-0.04
Q2 22
-33.3%
$-0.04vs$-0.03
Q3 22
-100.0%
$-0.06vs$-0.03
Q1 23
-400.0%
$-0.08vs$-0.02
Q1 23
+40.0%
$-0.03vs$-0.05
Q2 23
+40.0%
$-0.03vs$-0.05
Q3 23
-100.0%
$-0.06vs$-0.03
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Nov 18, 2024 | — | — | — | — |
Q3 2024 | Aug 9, 2024 | — | — | — | — |
Q2 2024 | May 31, 2024 | — | — | — | — |
Q1 2024 | Feb 12, 2024 | — | — | — | — |
Q4 2023 | Nov 29, 2023 | $-0.03 | — | — | — |
Q3 2023 | Aug 21, 2023 | $-0.03 | $-0.06 | -100.0% | ✗ MISS |
Q2 2023 | May 22, 2023 | $-0.05 | $-0.03 | +40.0% | ✓ BEAT |
Q1 2023 | Feb 14, 2023 | $-0.05 | $-0.03 | +40.0% | ✓ BEAT |
Q1 2023 | Jan 13, 2023 | $-0.02 | $-0.08 | -400.0% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | $-0.03 | $-0.06 | -100.0% | ✗ MISS |
Q2 2022 | May 16, 2022 | $-0.03 | $-0.04 | -33.3% | ✗ MISS |
Q1 2022 | Feb 14, 2022 | $-0.04 | $-0.04 | 0.0% | = MET |
Q1 2022 | Jan 18, 2022 | — | $-0.11 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.01 | — | — |
Q2 2021 | May 17, 2021 | — | $0.00 | — | — |
Q1 2021 | Feb 16, 2021 | — | $-0.02 | — | — |
Q4 2020 | Oct 29, 2020 | — | $-0.12 | — | — |
Q3 2020 | Aug 17, 2020 | — | $-0.03 | — | — |
Q3 2020 | Aug 14, 2020 | — | $-0.03 | — | — |
Q1 2020 | Feb 19, 2020 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about INLB
What is INLB's current stock price?
Item 9 Labs Corp. (INLB) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for INLB?
No analyst price targets are currently available for this stock.
What sector is Item 9 Labs Corp. in?
Item 9 Labs Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is INLB's market cap?
Item 9 Labs Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does INLB pay dividends?
No, Item 9 Labs Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBIOIF
Biome Grow Inc.
$0.00
Mkt Cap: $0.0B
CBGL
Cannabis Global, Inc.
$0.00
Mkt Cap: $0.0B
GREH
Green Rain Energy Holdings Inc.
$0.00
Mkt Cap: $0.0B
HENC
Hero Technologies Inc.
$0.00
Mkt Cap: $0.0B
ISOLF
Isodiol International Inc.
$0.00
Mkt Cap: $0.0B
JNHMF
Jack Nathan Medical Corp.
$0.00
Mkt Cap: $0.0B
LRDSF
Lords & Company Worldwide Holdings Inc.
$0.00
Mkt Cap: $0.0B
SAGD
South American Gold Corp.
$0.00
Mkt Cap: $0.0B
TRCNF
Transnational Cannabis Ltd.
$0.00
Mkt Cap: $0.0B
WRHLF
Love Hemp Group Plc
$0.00
Mkt Cap: $0.0B
Explore stocks similar to INLB for comparison